T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
National Beverage
FIZZ
$2.9B
| $572K | ﹤0.01% |
14,833
+3,581
| +32% | +$179K |
|
2052
Sally Beauty Holdings
SBH
$1.55B
| $568K | ﹤0.01% |
45,059
-4,062
| -8% | -$56.4K |
|
|
MTTR
2053
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $567K | ﹤0.01% |
149,585
+66,411
| +80% | +$293K |
|
|
PTRA
2054
DELISTED
Proterra Inc. Common Stock
PTRA
| $567K | ﹤0.01% |
113,681
+30,386
| +36% | +$170K |
|
2055
Enerpac Tool Group
EPAC
$1.91B
| $565K | ﹤0.01% |
31,653
-6,252,199
| -99% | -$122M |
|
2056
iShares Core Dividend Growth ETF
DGRO
$43.9B
| $563K | ﹤0.01% |
12,639
-800
| -6% | -$39.4K |
|
2057
Progress Software
PRGS
$1.79B
| $562K | ﹤0.01% |
13,186
+2,814
| +27% | +$130K |
|
|
OSG
2058
Octave Specialty Group
OSG
$210M
| $560K | ﹤0.01% |
43,895
+835
| +2% | +$11.1K |
|
2059
SkinHealth Systems
SKIN
$84.2M
| $560K | ﹤0.01% |
47,435
+11,317
| +31% | +$143K |
|
2060
PetMed Express
PETS
$43M
| $558K | ﹤0.01% |
28,543
+1,163
| +4% | +$24.7K |
|
2061
Lindsay Corp
LNN
$1.18B
| $556K | ﹤0.01% |
3,876
+1,727
| +80% | +$262K |
|
|
EVOP
2062
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $554K | ﹤0.01% |
16,619
+3,090
| +23% | +$95.4K |
|
2063
Horizon Bancorp
HBNC
$1.05B
| $552K | ﹤0.01% |
+30,671
| New | +$577K |
|
2064
MBIA
MBI
$254M
| $550K | ﹤0.01% |
59,741
+9,495
| +19% | +$113K |
|
2065
Archrock
AROC
$5.84B
| $549K | ﹤0.01% |
85,388
-42,526
| -33% | -$324K |
|
|
ALX
2066
Alexander's
ALX
$1.39B
| $547K | ﹤0.01% |
2,613
+828
| +46% | +$196K |
|
|
CLDT
2067
Chatham Lodging
CLDT
$590M
| $547K | ﹤0.01% |
55,338
-28,233
| -34% | -$340K |
|
|
DCT
2068
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $545K | ﹤0.01% |
45,947
-5,444,651
| -99% | -$72M |
|
2069
Cerence
CRNC
$391M
| $543K | ﹤0.01% |
34,470
+2,323
| +7% | +$52.2K |
|
|
VIA
2070
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $541K | ﹤0.01% |
15,644
-533
| -3% | -$21.1K |
|
|
CYBE
2071
DELISTED
Cyberoptics Corp
CYBE
| $541K | ﹤0.01% |
10,041
-2,544
| -20% | -$119K |
|
2072
Forrester Research
FORR
$220M
| $538K | ﹤0.01% |
14,938
-1,660
| -10% | -$71.3K |
|
2073
Vishay Precision Group
VPG
$908M
| $538K | ﹤0.01% |
18,160
+2,160
| +14% | +$68.7K |
|
2074
Coherus Oncology
CHRS
$181M
| $537K | ﹤0.01% |
55,776
+4,447
| +9% | +$45K |
|
2075
Banner Corp
BANR
$2.5B
| $535K | ﹤0.01% |
9,040
+2,193
| +32% | +$132K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.